Clinical Trial Detail

NCT ID NCT03769311
Title Cetuximab in Head and Neck Cancer Patients
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab

Age Groups: adult senior

No variant requirements are available.